Survival Outcomes for Metastatic RCC and Sarcomatoid Dedifferentiation
Matthew T. Campbell, MD, discusses survival outcomes for patients with both metastatic renal cell carcinoma and sarcomatoid dedifferentiation and how they each have evolved over the past few years.
RCC With Sarcomatoid Features May Benefit From Immunotherapy
Matthew T. Campbell, MD, discusses the results of a retrospective analysis of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation.
Addressing Unmet Needs in Renal Cell Carcinoma
Matthew T. Campbell, MD, discusses the unmet needs for patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Upcoming Trials Show Promise With Cabozantinib in RCC
Matthew T. Campbell, MD, MS, discusses trials investigating cabozantinib in patients with renal cell carcinoma.
